Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies. Kemmotsu N, Ninomiya K, Kunimasa K, Ishino T, et al. Int J Cancer 2024;154:169-179.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kemmotsu N, Ninomiya K, Kunimasa K, Ishino T, et al. Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies. Int J Cancer 2024;154:169-179.
PMID: 37611176